Early results show that the combination of VXM01 plus avelumab demonstrated tolerable safety in recurrent glioblastoma.

Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with ...

RNA vaccines are composed of the nucleic acid RNA, which encode antigen genes of an infectious agent. When administered to host cells, the RNA is translated into protein antigens that elicit ...

Results from Phase 2a Trial demonstrate a good safety and tolerability profile of VXM01 and Avelumab Combination Therapy in Glioblastoma, supporting further ...

The Moderna, Pfizer-BioNTech, and Novavax vaccines protect against many known variants of COVID-19. The Moderna and Pfizer-BioNTech vaccines offer immunity against COVID-19 for up to six months. To ...

With the virus spreading rapidly around the world, the need for a vaccine was desperate — but the prior record for the fastest development of a new vaccine to a new virus was four years.

The current measles outbreak might make you wonder whether you need a booster vaccine. If you’re fully vaccinated—meaning you have received two doses of the MMR (measles-mumps-rubella) vaccine—you ...

The Centers for Disease Control and Prevention is initiating expanded research into understanding autism and its potential links with vaccines, a source familiar with the CDC’s planning said.

Kennedy Jr., who has long expressed skepticism about the safety of vaccines and has vowed to revisit the data. “As President Trump said in his Joint Address to Congress, the rate of autism in ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.

This is a KFF Health News story. Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving COVID shots.